Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 2Gynecologic 1

Conditions

Ovarian Neoplasms 142Endometrial Neoplasms 85Uterine Cervical Neoplasms 71Breast Neoplasms 42Fallopian Tube Neoplasms 38Colorectal Neoplasms 34Carcinoma, Non-Small-Cell Lung 32Pancreatic Neoplasms 24Neoplasms 23Prostatic Neoplasms 22Neoplasm Metastasis 21Stomach Neoplasms 19Triple Negative Breast Neoplasms 18Urinary Bladder Neoplasms 17Esophageal Neoplasms 17Melanoma 16Squamous Cell Carcinoma of Head and Neck 15Lung Neoplasms 15Carcinoma, Renal Cell 15Carcinoma, Ovarian Epithelial 15Head and Neck Neoplasms 14Sarcoma 13Carcinoma, Hepatocellular 13Uterine Neoplasms 11Colonic Neoplasms 11Cholangiocarcinoma 11Carcinoma, Transitional Cell 11Rectal Neoplasms 10Vulvar Neoplasms 9Small Cell Lung Carcinoma 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Risk Reduction Behavior × Gynecologic × 30 days × Clear all
NCT00040222 2026-06-01

Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

National Institutes of Health Clinical Center (CC)

Completed
377 enrolled
BreastGynecologic

Breast Cancer, Familial, Breast Neoplasms, Hamartoma Syndrome, Multiple, Ovarian Neoplasms, Peutz-Jeghers Syndrome, Li-Fraumeni Syndrome, Risk Reduction Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡